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Background: Hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE) is characterized by recurrent edema
of unpredictable frequency and severity. Stress, anxiety, and low mood are among the triggering factors most
frequently reported. Impaired regulation and processing of emotions, also known as alexithymia, may influence
outcomes. The aim of this study was to confirm the presence of alexithymia and stress in children with C1-INH-HAE,
to determine whether they are also present in children affected by other chronic diseases, and to investigate their
relationship with C1-INH-HAE severity. Data from children with C1-INH-HAE (n = 28) from four reference centers in
Italy were compared with data from children with type 1 diabetes (T1D; n = 23) and rheumatoid arthritis (RA;
n = 25). Alexithymia was assessed using the Alexithymia Questionnaire for Children scale; perceived stress was
assessed using the Coddington Life Event Scale for Children (CLES-C).
Results: Mean age (standard deviation [SD]) in the C1-INH-HAE, T1D, and RA groups was 11.8 (3.3), 11.7 (2.9), and
11.1 (2.6) years, respectively. Mean C1-INH-HAE severity score was 5.9 (2.1), indicating moderate disease. Alexithymia
scores were similar among disease groups and suggestive of difficulties in identifying and describing emotions;
CLES-C scores tended to be worse in C1-INH-HAE children. C1-INH-HAE severity was found to correlate significantly
and positively with alexithymia (p = 0.046), but not with perceived stress. Alexithymia correlated positively with
perceived stress.
Conclusions: Alexithymia is common in children with chronic diseases. In C1-INH-HAE, it may result in increased
perceived stress and act as a trigger of edema attacks. Comprehensive management of C1-INH-HAE children should
consider psychological factors.
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Hereditary angioedema with C1-inhibitor deficiency
(C1-INH-HAE) is a rare autosomal dominant disorder
with a reported prevalence of approximately 1 case per
50,000 persons [1, 2]. It is caused by mutations in the
SERPING1 gene encoding the serpin-type protease in-
hibitor C1-INH [1]. Quantitative or qualitative deficiency
of C1-INH results in the uncontrolled activation of the
complement and contact pathways leading to the release
of vasoactive substances including bradykinin, a key me-
diator of enhanced vascular permeability and edema for-
mation [2]. C1-INH-HAE is characterized by recurrent
subcutaneous and/or submucosal edema, without wheals
or pruritus. Clinical manifestations exhibit high intra- and
inter-individual variability and angioedema attacks occur
with unpredictable frequency and severity. Swelling at-
tacks typically affect the skin, upper airway, and gastro-
intestinal tract; abdominal attacks can be very painful and
laryngeal attacks can be life-threatening due to the risk of
asphyxiation [2]. C1-INH-HAE imposes a considerable
burden on affected patients and their families, during and
between angioedema episodes [3–6]. The reported age of
onset of C1-INH-HAE attacks ranges from 4 to 18 years
[7]. In children, C1-INH-HAE significantly impairs quality
of life (QoL) and is associated with increased anxiety
levels [8, 9].
The reasons for the high variability and unpredict-
ability of C1-INH-HAE manifestations are still poorly
understood [10]. Although most attacks appear to
occur spontaneously, some factors triggering the onset
of angioedema are known, including emotional stress
and anxiety, physical trauma, medical or dental proce-
dures, infection, and changes in estrogen levels [11, 12].
Emotional states are known to influence physical health
[13]. Indeed, stress, anxiety, and low mood are the most
frequent triggers reported by patients with C1-INH-HAE
[14]. At the same time, C1-INH-HAE itself causes anxiety
and depression, which leads to a vicious circle of increased
emotional stress and higher attack frequency [14, 15]. In
recent years, several studies have suggested the interaction
of the immune system with the central nervous system to
explain the effects of mood and anxiety on inflammatory
diseases [15, 16]. A study in patients with C1-INH-HAE
showing an increase in sympathetic activation at rest and
a blunted response to experimentally induced stress have
suggested that autonomous nervous system function may
be altered [17]. Overall, studies addressing specifically the
role of stress and psychological factors in C1-INH-HAE
are still very limited, especially in children [10, 18, 19].
In a recent study we evaluated, for the first time in chil-
dren, the psychological profile, the perceived level of
stress, and the ability to cope with emotions of 12 children
with C1-INH-HAE [18]. The majority of parents, who
were also recruited in the study, indicated emotional stressas a trigger of angioedema attacks. Stress levels measured
using the Coddington Life Events Scale (CLES) appeared
to be higher in children with C1-INH-HAE compared
with age-matched healthy controls. Furthermore, all chil-
dren showed impaired ability to recognize and describe
their feelings, as assessed by the Alexithymia Question-
naire for Children (AQC) and the Level of Emotional
Awareness Scale for Children. The concept of alexithymia
refers to the lack of words for emotions and was intro-
duced in the early 1970s from the observation of patients
with classic psychosomatic diseases [20–22]. The concept
encompasses various deficits in the cognitive processing
of emotions, including difficulty in identifying feelings, dif-
ficulty in describing feelings to others, externally oriented
thinking, and a limited imaginative capacity [22]. Alexithy-
mia is considered a key element in the psychosomatic
process and in the neurologic mechanisms causing phys-
ical illness [23]. The presence of alexithymia is generally
considered to be an unfavorable characteristic for disease
control and health promotion [24].
We present here the results of a study that we con-
ducted to further evaluate the relationship between emo-
tional processes and disease manifestations in children
with C1-INH-HAE and in two control groups, namely
children with type 1 diabetes (T1D) and rheumatoid arth-
ritis (RA). The objectives of the study were: 1) to confirm
the presence of alexithymia and high levels of perceived
stress in a larger population of C1-INH-HAE children; 2)
to determine whether the presence of alexithymia and
stress is specific for C1-INH-HAE; and 3) to establish
whether C1-INH-HAE severity correlates with alexithy-
mia, perceived stress and anxiety.
Methods
Study design and patients
This was a multicenter, exploratory study conducted in
children with C1-INH-HAE to investigate the presence of
psychological factors and their correlation with disease se-
verity. The study also included two control populations
consisting of children affected by other chronic diseases,
namely T1D and RA. T1D patients were selected as con-
trol because T1D is the chronic condition with the highest
incidence among children and has well-established proto-
cols for disease control and patient management in the
pediatric setting. RA patients were selected as this condi-
tion is characterized by a high variability of symptoms in
children similar to C1-INH-HAE.
Patients and their parents were recruited via phone
calls, based on medical records and with cooperation of
their physicians. C1-INH-HAE patients were recruited
from the center coordinating the study (University
Hospital Federico II, Naples, Italy) and from three add-
itional HAE reference centers in Italy (Rome, Padua,
and Milan). T1D and RA patients were recruited from
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rheumatology of the coordinating center. Patients were
aged ≥6 years and ≤ 17 years and had been diagnosed with
their chronic condition for at least 2 years. All procedures
performed in this study were in accordance with the
ethical standards of the study coordinating center and
with the 1964 Helsinki Declaration and its later amend-
ments or comparable ethical standards. Prior to study par-
ticipation, patients and their parents signed an informed
consent. Children received age-specific versions of the in-
formed consent document [18].
Assessments
Demographic and clinical data were collected from pa-
tient medical charts and diaries. Study assessments
were performed during two face-to-face meetings for
each study patient; the first meeting (45 min) was with
the parents and the second meeting was with the child
(90 min, approximately). At the first meeting, parents
were administered the questionnaire Child Behavior
Check-List, based on which the presence of psycho-
pathological conditions was ruled out [25, 26]. During
the meeting with the child, perceived stress and psycho-
logical factors were evaluated using the following tools:
Coddington Life Events Scale for Children (CLES-C);
Alexithymia Questionnaire for Children (AQC), or
Toronto Alexithymia Scale 20 (TAS-20) in children aged
> 15 years; Physiological Hyperarousal in Children
(PH-C). The questionnaires were administered to the chil-
dren by trained personnel; validated Italian translations of
the questionnaires were used. The CLES-C is a validated
and well-established 36-item questionnaire, which mea-
sures the frequency and timing of both positive and
negative life events relevant for this age group during
the last year (four trimesters) [27, 28]. By measuring
significant life events in terms of Life Change Units, the
CLES-C can provide insight into recent events that
may be affecting the child’s health. Children with a
score above the age-specific cut-offs (ie, a “critical
score”) are considered to be at higher risk to suffer
from psychological problems. The AQC is an adapta-
tion of the TAS-20 that assesses alexithymia in adults
[29]. The AQC consists of 20 items, which are reformu-
lated for children and represent the three factors
“Difficulty identifying feelings”, “Difficulty describing feel-
ings” and “Externally oriented thinking”. There are three
possible responses to the various items: “not true”, “a bit
true”, “true”. The Italian version of the AQC contains four
factors, the three of the English version plus a factor
related to confused physical perceptions, which focuses on
aspects of emotions concerning the body [30]. Higher
AQC scores correspond to a greater impairment in the
recognition and verbalization of emotions (score >
30.17 defines critical AQC for the age group 7–10 years;score > 28.22 defines critical AQC for the age group
11–14 years) [29, 30]. Critical scores for the CLES-C
and ACQ were defined by previous studies in a range of
healthy children unaffected by chronic disease [27–30].
The PH-C consists of 18 items that assess somatic arousal,
defined as bodily manifestations of autonomic arousal
[31]. Elevated levels of somatic arousal (physiological hy-
perarousal) represent anxiety. In the PH-C, children rate
on a 5-point scale (from 1 = never to 5 = all the time) how
often they have experienced symptoms such as sweaty
hands, feeling of choking, heart pounding, during the past
2 weeks. Higher scores indicate higher levels of physio-
logical hyperarousal.
Disease severity in C1-INH-HAE patients was evaluated
using the clinical severity score designed by Bygum and
colleagues, based on information collected from patient
charts and parent and children interviews [4]. The disease
severity score ranges from 0 to 10 and takes into account
age at disease onset, clinical manifestations (edema
location, occurrence of painful abdominal edema) and
treatment experiences (need for long-term prophylaxis).
Highest scores indicate more severe disease.
Statistical analysis
Data were summarized by descriptive analysis. Means and
SD were calculated for continuous variables, while abso-
lute values and frequency (percentage) were calculated for
categorical variables. Analysis of variance and Chi Square
tests were used to examine the significance of the differ-
ences between groups for continuous and categorical vari-
ables, respectively. Correlations between C1-INH-HAE
severity and alexithymia, perceived stress and other pa-
rameters were assessed using general linear models or lo-
gistic regression analysis when the dependent variable was
dichotomous. All tests were two-sided and the level of sig-
nificance was set at p ≤ 0.05 for all analyses.
Results
Overall, 28 children with C1-INH-HAE, 23 with T1D,
and 25 with RA were enrolled in this study (Table 1).
Mean age (standard deviation [SD]) in the three groups
was 11.8 (3.3), 11.7 (2.9), and 11.1 (2.6) years, respect-
ively. Most patients with C1-INH-HAE (75%) had fam-
ily members affected by C1-INH-HAE, while a family
history was less prevalent in T1D and RA patients. In
the C1-INH-HAE group, boys were the majority
(67.9%), while in the other two groups, the majority of
patients were girls. Frequency of symptoms (swelling
and angioedema attacks in C1-INH-HAE patients,
hyper- and hypoglycemia in patients with T1D, and
joint pain in patients with RA) over the past 12 months
was similar among disease groups. Overall, a symptom
frequency of ≥2 events per trimester was reported by
48–57% of children over the previous 12 months.
Table 1 Baseline demographics
Demographic Hereditary
angioedema
Type 1
diabetes
Rheumatoid
arthritis
N = 28 N = 23 N = 26
Age, yrs., mean (SD) 11.8 (3.3) 11.7 (2.9) 11.1 (2.5)
Gender, n (%)
Female 9 (32.1) 17 (73.9) 16 (61.5)
Male 19 (67.9) 6 (26.1) 10 (38.5)
Family history, n (%)
Yes 21 (75.0) 5 (21.7) –a
No 7 (25.0) 18 (78.3) 24 (100.0)
aFamily history was unavailable for two patients
SD, standard deviation; yrs., years
Table 3 Alexithymia in patients with hereditary angioedema
and control groups
Disease DIF DDF EOT CPF TAS
C1-INH-HAE 11.3 (4.0) 8.9 (2.8) 13.6 (2.7) 5.6 (2.1) 34.4 (6.7)
T1D 13.1 (3.6) 9.9 (3.2) 14.1 (2.3) 6.6 (2.2) 36.5 (6.8)
RA 13.4 (4.4) 9.7 (2.9) 13.5 (2.0) 6.9 (2.5) 36.6 (8.0)
Data are presented as mean (standard deviation). Analysis of variance p-values
for DIF, DDF, EOT, CPF, and total score were 0.181, 0.452, 0.731, 0.171, 0.480,
respectively
C1-INH-HAE hereditary angioedema with C1-inhibitor deficiency, CPF confusion
in physical sensations, DDF difficulty describing feelings, DIF difficulty
identifying feelings, EOT externally-oriented thinking, RA rheumatoid arthritis,
TAS total alexithymia score, T1D type 1 diabetes
Savarese et al. Orphanet Journal of Rare Diseases  (2018) 13:115 Page 4 of 8On average, children had experienced between 2 and 3
attacks during the previous month (Table 2). With re-
gard to the attacks reported over the past 12 months,
most patients had skin (89.3%) and abdominal attacks
(82.1%); laryngeal attacks were reported by approxi-
mately 40% of patients. The mean (SD) disease severity
score was 5.9 (2.1). Disease severity was comparable be-
tween male and female patients, with the latter group
showing a trend towards a higher mean disease score. In
addition, the disease severity score appeared to increase
with age, while the number of attacks over the past
month showed a decreasing trend with age.
According to the results of the analysis of alexithymia
using the AQC questionnaire, patients in all three
groups showed difficulties in identifying and describing
feelings, were prone to externally-oriented thinking,
and were moderately confused about their physical per-
ceptions (Table 3). A greater proportion of children
with C1-INH-HAE showed a level of alexithymia that
was defined as critical, compared with children with
T1D or RA (p = 0.506; Fig. 1). Of note, C1-INH-HAETable 2 Clinical characteristics of patients with hereditary
angioedema
Clinical characteristic N = 28
Number of attacks during past month, median (range) 2.5 (0–8.0)
Age at disease onset, yrs., mean (SD) 2.4 (0.8)
Use of prophylaxis therapy, n (%)
Yes 4 (14.3)
No 24 (85.7)
Site of angioedema attacksa, n (%)
Skin 25 (89.3)
Abdomen 23 (82.1)
Larynx 11 (39.3)
Total disease severity score, mean (SD) 5.9 (2.1)
aReferred to attacks experienced during the 12 months preceding
the interview
SD, standard deviation; yrs., yearschildren with critical AQC reported a higher mean total
disease severity score [6.4 (1.8)] than those with
non-critical AQC [5.3 (2.6)].
Compared with children in the two control groups,
those with C1-INH-HAE reported more stressful events
over the 12 months prior to the study interview. A
greater proportion of children in the C1-INH-HAE
group (64%) showed critical CLES-C scores compared
with children in the T1D and RA groups (53 and 45%,
respectively, p = 0.401; Fig. 2). As for PH-C scores,
children with RA reported the highest mean scores [34.4
(12.5)], followed by children with T1D [30.7 (7.9)] and
C1-INH-HAE [29.4 (11.7)]. Differences between groups
were not statistically significant (p = 0.436).
The analysis of the relationship between C1-INH-HAE
severity score and the scores related to the ability to
recognize and describe feelings found a statistically sig-
nificant positive correlation between total severity score
and AQC score (p = 0.046). No statistically significant
correlation was found between the total severity score
and CLES-C scores, and between C1-INH-HAE attack
frequency and the AQC score. Notably, AQC scores
were found to correlate significantly and positively with
CLES-C scores (Additional file 1: Table S1). Thus,
increasing levels of alexithymia were associated with
increasing odds of experiencing critical levels of per-
ceived stress.
Discussion
The majority of children with C1-INH-HAE in the
present study showed critical alexithymia and critical
levels of perceived stress, consistent with our previous
observations [18]. This was true also for children af-
fected by T1D and RA, suggesting that alexithymia and
stress are common features of chronic illnesses in this
age group. The proportions of children with critical
AQC and CLES-C scores were consistently more ele-
vated in C1-INH-HAE patients compared with the two
control groups, indicating that impairment in regulation
and processing of emotions as well as stress may be
more relevant in C1-INH-HAE children. The severity of
Fig. 1 Patients with hereditary angioedema and controls with non-critical and critical alexithymia
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positively with alexithymia, but not with perceived stress.
A significant correlation was found also between alex-
ithymia and perceived stress, which suggests that the in-
ability to identify and describe feelings may result in
reduced abilities to cope with stress.
Currently we can only speculate about the reasons
why children affected by chronic diseases show alex-
ithymia. Several studies have suggested that experiences
of adversity early in life, for example poverty, but also
psychological distress, can have a negative impact on
emotional functioning and other health-related aspects
[13, 32, 33]. Thus, the psychological distress associated
with the burden of chronic disease during childhood
may be a cause of impaired emotional processing and
alexithymia. Moreover, in the attempt to avoid triggers,
parents may implicitly discourage the contact with emo-
tional states in their children, due to a fear of emotions as
triggers of attacks [10]. At the same time, psychologicalFig. 2 Patients with hereditary angioedema and controls non-critical and cdistress may also be a consequence of the high levels of
stress perceived by these patients [27].
In our first study investigating psychological factors in
children with C1-INH-HAE, all interviewed parents in-
dicated stress and emotions – both positive and negative
– as the most frequent triggers of angioedema attacks
and, thus, as the factors potentially involved in the high
variability of attack occurrence [18]. A recent study in-
vestigating various aspects of C1-INH-HAE in Swedish
children (median age, 9 years), based on a questionnaire
answered mostly by the parents, also found that psycho-
logical stress is the most commonly reported trigger of
abdominal attacks [34].
The unpredictability of angioedema attacks is often con-
sidered as more distressing than the physical symptoms of
the attack [3, 6, 10]. The uncertainty associated with an-
gioedema attacks further complicates everyday life, be-
cause the planning of any activity can be very difficult
[10]. A study evaluating health-related QoL (HRQoL) inritical perceived stress
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self-report and on parent proxy reports (PedsQL™ 4.0)
found that the fear of a sudden angioedema attack causes
emotional distress and anxiety [8]. Due to this fear, pa-
tients often avoid activities and social life, which further
worsens emotional distress and impairment of HRQoL.
Other authors have pointed to the psychosocial factors
that appear between attacks, including stress driven by
uncertainty, as important contributors to the disease bur-
den [14]. As a consequence, interventions that target psy-
chological aspects and help patients to achieve emotional
control are increasingly regarded as potential strategies for
reducing the chances to trigger an attack [9].
The importance of emotional awareness and the poten-
tial of psychological interventions aimed at reducing alex-
ithymia is supported by a number of reports from other
therapeutic areas and mostly in adults [35–37]. In a case
series including adult patients with chronic musculoskel-
etal pain, emotion-oriented interventions were associated
with clinically relevant improvements in pain intensity,
interference, depression and distress, and with a decrease
in alexithymia as assessed by the Levels of Emotional
Awareness Scale score [35]. The interventions included
attributing pain to psychological processes, emotional
awareness and expression, and engaging in desired
activities despite pain. It was, however, pointed out by the
authors that this approach, which attributes pain mainly
to mental processes, does not apply to all patients [35].
Indeed, in patients with chronic pain caused by peripheral
disease processes or structural alterations, emotional
problems are usually the consequence rather than the
cause of pain. A study in patients with irritable bowel syn-
drome (IBS) identified alexithymia as a strong predictor of
IBS severity suggesting that altered emotion awareness
and processing may result in clinical manifestations of IBS
[36, 37]. The authors highlighted that improving the abil-
ity to recognize emotions and to deal with them may lead
to better treatment outcomes, especially in patients with
high alexithymia [37].
Despite a number of limitations, such as the limited
sample size and the lack of a control group of healthy
children, the present study demonstrates that psycho-
logical assessments are feasible in children aged 6–17 years
(mean age of the C1-INH-HAE patients, 11.8 years). The
comparators in our study were children with other forms
of chronic disease, rather than healthy children, but we
were also able to show that a high proportion of
C1-INH-HAE children have critical scores for alexithy-
mia and perceived stress derived from validation studies
conducted in healthy children. Assessment of stress
and anxiety in children with chronic diseases are chal-
lenging, but the evidence from our studies, as well as
from the reports by other authors, shows that children
aged ≥7 years are able to evaluate their anxiety [38].Overall, children continue to be underrepresented in
clinical trials and the need for children-specific assess-
ment tools is recognized also in the C1-INH-HAE field.
The use of self-reported tools for evaluating anxiety
and other psychological factors in children should be
encouraged as parent-reported proxy tools may not be
always adequate [38].
Conclusions
In C1-INH-HAE, which is characterized by a very high
variability of symptom manifestations, the presence of
marked alexithymia might be predictive of even worse
outcomes. Our findings suggest that impaired emo-
tional competence may also lead to an increase in per-
ceived stress, which is a possible trigger of angioedema
attacks. Perceived stress, emotional competence, and
anxiety should be assessed in children with chronic
diseases. As recommended by current guidelines for
the management of children with C1-INH-HAE, pro-
grams for comprehensive patient management should
also include psychological interventions, if needed, and
encourage the cooperation between physicians and psy-
chologists [7]. Individual and group psychological inter-
ventions aimed at improving the ability of children
with C1-INH-HAE to recognize their feelings and to
cope with them should be offered to children and their
parents. Such interventions may help reduce stress
levels and, ultimately, control factors that trigger at-
tacks and contribute to the unpredictability of disease
manifestations.
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